Role of nitric oxide in the development of cardiac lesions during the acute phase of experimental infection by Trypanosoma cruzi;Papel do óxido nítrico no desenvolvimento de lesões cardíacas na fase aguda da infecção experimental pelo Trypanosoma cruzi

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 42, Issue 2, 2009, Pages 170-174

  Borges, Cláudia Renata Bibiano ^a   Rodrigues Jr , Virmondes ^a   Dos Reis, Marlene Antônia ^a   Castellano, Lúcio Roberto ^a   Chica, Javier Emilio Lazo ^a   Pereira, Sanívia Aparecida De Lima ^b   Santos, Edjane Souza ^a   Rodrigues, Denise Bertulucci Rocha ^a,b  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

^b UNIVERSITY OF UBERABA   (Brazil)

Author keywords

Chagas disease; Fibrosis; Inflammation; Nitric oxide

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; EXPERIMENTAL INFECTION; HEART INJURY; HEART MUSCLE FIBROSIS; MOUSE; NONHUMAN; TRYPANOSOMA CRUZI;

ACUTE DISEASE; ANIMALS; CHAGAS CARDIOMYOPATHY; FIBROSIS; MICE; MICE, INBRED C57BL; MYOCARDITIS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; SPECIES SPECIFICITY; TRYPANOSOMA CRUZI;

ANIMALIA; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 65949099938     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822009000200015     Document Type: Article

References (33)

1. Abel LC, Rizzo LV, Ianni B, Albuquerque F, Bacal F, Carrara D, Bocchi EA, Teixeira HC, Mady C, Kalil J, Cunha-Neto E. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. Journal of Autoimmunity 17:99-107, 2001.
2. Almeida-Leite CM, Galvão LM, Afonso LC, Cunha FQ, Arantes RM. Interferon-gamma induced nitric oxide mediates in vitro neuronal damage by Trypanosoma cruzi-infected macrophages. Neurobiology of Disease 25:170-178, 2007.
3. Andrade S. Caracterização de cepas do Trypanosoma cruzi isoladas no Recôncavo Baiano. Revista de Patologia Tropical 3:65-121, 1974.
4. Andrade Z. Patologia da doença de Chagas. In: Brener Z, Andrade Z, Barral-Neto M (eds) Trypanossoma cruzi e Doença de Chagas. Guanabara Koogan, Rio de Janeiro, p.201-230, 2000.
5. Arantes RM, Marche HH, Bahia MT, Cunha FQ, Rossi MA, Silva JS. Interferon-gamma-induced nitric oxide causes intrinsic intestinal denervation in Trypanosoma cruzi-infected mice. American Journal of Pathology 164:1361-1368, 2004.
6. Aretz HT. Myocarditis: the Dallas criteria. Human Pathology 18:619-624, 1987.
7. Bahia-Oliveira LM, Gomes JA, Cançado JR, Ferrari TC, Lemos EM, Luz ZM, Moreira MC, Gazzinelli G, Correa-Oliveira R. Immunological and clinical evaluation of chagasic patients subjected to chemotherapy during the acute phase of Trypanosoma cruzi infection 14-30 years ago. The Journal of Infectious Diseases 182:634-638, 2000.
8. Caliari MV, de Lana M, Caja RA, Carneiro CM, Bahia MT, Santos CA, Magalhães GA, Sampaio IB, Tafuri WL. Immunohistochemical studies in acute and chronic canine chagasic cardiomyopathy. Virchows Archiv 441:69-76, 2002.
9. Chagas C. Processos patojenicos da tripanozomiase americana. Memórias do Instituto Oswaldo Cruz 8: 5-35, 1916.
10. Chandra M, Tanowitz HB, Petkova SB, Huang H, Weiss LM, Wittner M. Factor SM, Shtutin V, Jelicks LA, Chan J, Shirani J. Significance of inducible nitric oxide synthase in acute myocarditis caused by Trypanosoma cruzi (Tulahuen strain). International Journal for Parasitology 32:897-905, 2002.
11. Gazzinelli RT, Oswald IP, Hieny S, James SL, Sher A. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. European Journal of Immunology 22:2501-2506, 1992.
12. Guimarães M, Mázaro R. Princípios Éticos e Práticos do Uso de Animais de Experimentação. Universidade Federal de São Paulo, São Paulo, 2004.
13. Hally A. A counting method for measuring the volumes of tissue components in microscopical sections. The Quarterly Journal of Microscopical Science 105:503, 1964.
14. Hesse M, Cheever AW, Jankovic D, Wynn TA. NOS-2 mediates the protective anti-inflammatory and antifibrotic effects of the Th1-inducing adjuvant, IL-12, in a Th2 model of granulomatous disease. The American Journal of Pathology 157:945-955, 2000. (Pubitemid 32109386)
15. Higuchi ML. Chagas disease. Importance of the parasite in the pathogenesis of the cardiac chronic disease. Arquivos Brasileiros de Cardiologia 64:251-254, 1995.
16. Holscher C, Kohler G, Muller U, Mossmann H, Schaub GA, Brombacher F. Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infection and Immunity 66:1208-1215, 1998.
17. Jones EM, Colley DG, Tostes S, Lopes ER, Vnencak-Jones CL, McCurley TL. Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. The American Journal of Tropical Medicine and Hygiene 48:348-357, 1993.
18. Lopes E, Chapadeiro E. Anatomia patológica da doença de Chagas humana. In: Dias J, Coura J (eds) Clínica e terapêutica da doença de Chagas. Uma abordagem prática para o clínico geral. Fundação Oswaldo Cruz, Rio de Janeiro, p.67-84, 1997.
19. Mandarim-de-Lacerda CA. Stereological tools in biomedical research. Anais da Academia Brasileira de Ciências 75:469-486, 2003.
20. Mayer B, Schmidt K, Humbert P, Bohme E. Biosynthesis of endothelium derived relaxing factor: a cytosolic enzyme in porcine aortic endothelial cells Ca2+-dependently converts L-arginine into an activator of soluble guanylyl cyclase. Biochemical and Biophysical Research Communications 164:678-685, 1989. (Pubitemid 19280322)
21. Mezadri T, Thomáz V, Amaral V. Animais de laboratório: 9 cuidados na iniciação experimental. Florianópolis, 2004.
22. Mortara RA, Procopio DO, Barros HC, Verbisck NV, Andreoli WK, Silva RB, Silva S. Features of host cell invasion by different infective forms of Trypanosoma cruzi. Memórias do Instituto Oswaldo Cruz 94 (supl 1):135-137, 1999.
23. Munoz-Fernandez MA, Fernandez MA, Fresno M. Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF- alpha and IFN-gamma through a nitric oxide-dependent mechanism. Immunology Letters 33:35-40, 1992.
24. Palomino SA, Aiello VD, Higuchi ML. Systematic mapping of hearts from chronic chagasic patients: the association between the occurrence of histopathological lesions and Trypanosoma cruzi antigens. Annals of Tropical Medicine and Parasitology 94:571-579, 2000.
25. Rassi A. Clínica: fase aguda. In: Brener Z, Andrade Z (eds) Trypanosoma cruzi e doença de Chagas. Guanabara Koogan, Rio de Janeiro, p.249-264, 1979.
26. Reed SG. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections. The Journal of Immunology 140:4342-4347, 1988.
27. Sacks D, Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nature Reviews Immunology 2:845-858, 2002.
28. Sher A, Coffman RL. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annual Review of Immunology 10:385-409, 1992.
29. Silva JS, Morrissey PJ, Grabstein KH, Mohler KM, Anderson D, Reed SG. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. The Journal of Experimental Medicine 175:169-174, 1992.
30. Silva JS, Vespa GN, Cardoso MA, Aliberti JC, Cunha FQ. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon- activated macrophages. Infection and Immunity 63:4862-4867, 1995.
31. Toledo MJ, Bahia MT, Veloso VM, Carneiro CM, Machado-Coelho GL, Alves CF, Martins HR, Cruz RE, Tafuri WL, Lana M. Effects of specific treatment on parasitological and histopathological parameters in mice infected with different Trypanosoma cruzi clonal genotypes. The Journal of Antimicrobial Chemotherapy 53:1045-1053, 2004.
32. Vespa GN, Cunha FQ, Silva JS. Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infection and Immunity 62:5177-5182, 1994.
33. Vianna G. Contribuição para o estudo da anatomia patolojica da "Molestia de Carlos Chagas": esquizotripanoze humana ou tireoidite parazitaria. Memórias do Instituto Oswaldo Cruz 3: 276-292, 1911.